Search

Your search keyword '"KALYONCU, Mukaddes"' showing total 315 results
Start Over Author "KALYONCU, Mukaddes"
315 results on '"KALYONCU, Mukaddes"'

1. Evaluation of pediatric rheumatologists’ approach to rituximab use: a questionnaire study

Author

Sunar Yayla, Emine Nur, Gezgin Yıldırım, Deniz, Adıgüzel Dündar, Hatice, Adrovic, Amra, Akbörü, Elifsu Gözde, Aktay Ayaz, Nuray, Aliyev, Emil, Avar Aydın, Pınar Özge, Aydın, Fatma, Baba, Özge, Bağlan, Esra, Bora Makay, Balahan, Bozkaya Yücel, Burcu, Çakan, Mustafa, Çelikel, Elif, Demir, Ferhat, Demir, Selcan, Demirkan, Fatma Gül, Ekici Tekin, Zahide, Esmeray Şenol, Pelin, Guliyeva, Vefa, Güngörer, Vildan, İşgüder, Rana, Kalyoncu, Mukaddes, Karadağ, Şerife Gül, Kısaoğlu, Hakan, Kışla Ekinci, Rabia Miray, Kızıldağ, Zehra, Kurt, Tuba, Özdel, Semanur, Özdemir Çiçek, Sümeyra, Öztürk, Kübra, Polat, Merve Cansu, Sezer, Müge, Sönmez, Hafize Emine, Sözeri, Betül, Şener, Seher, Taşkın, Sema Nur, Türkuçar, Serkan, Ünsal, Erbil, Yıldız, Çisem, and Bakkaloğlu, Sevcan A.

Published
2024
Full Text
View/download PDF

2. Adolescence-onset atypical hemolytic uremic syndrome: is it different from infant-onset?

Author

Celegen, Kubra, Gulhan, Bora, Fidan, Kibriya, Yuksel, Selcuk, Yilmaz, Neslihan, Yılmaz, Aysun Caltik, Demircioğlu Kılıç, Beltinge, Gokce, Ibrahim, Kavaz Tufan, Aslı, Kalyoncu, Mukaddes, Nalcacıoglu, Hulya, Ozlu, Sare Gulfem, Kurt Sukur, Eda Didem, Canpolat, Nur, K. Bayazit, Aysun, Çomak, Elif, Tabel, Yılmaz, Tulpar, Sebahat, Celakil, Mehtap, Bek, Kenan, Zeybek, Cengiz, Duzova, Ali, Özçakar, Zeynep Birsin, Topaloglu, Rezan, Soylemezoglu, Oguz, and Ozaltin, Fatih

Published
2024
Full Text
View/download PDF

3. Towards a standardized program of transitional care for adolescents with juvenile idiopathic arthritis for Turkey: a national survey study

Author

Sözeri, Betül, Şahin, Nihal, Açarı, Ceyhun, Avar Aydın, Pinar Ozge, Baba, Ozge, Bağlan, Esra, Bakkaloğlu, Sevcan, Bakırcı, Sibel, Bilginer, Yelda, Bozkaya, Burcu Yücel, Çağlayan, Şengül, Çakan, Mustafa, Çakmak, Figen, Coşkuner, Taner, Demir, Ferhat, Demirkan, Fatma Gül, Doğantan, Şeyda, Adıgüzel Dündar, Hatice, Ersözlü, Emine Duygu, Gücenmez, Sercan, Gürler, Oğuz, İşgüder, Rana, Küçük, Adem, Kalyoncu, Mukaddes, Kılıç, Levent, Kılıç, Sara Şebnem, Kısaoğlu, Hakan, Paç Kısaarslan, Ayşenur, Kızıldağ, Zehra, Kurtuluş, Duygu, Özdel, Semanur, Öztürk, Kübra, Şenol, Pelin, Tanatar, Ayşe, Taşkın, Sema Nur, Tuncer Kuru, Fatma, Türkuçar, Serkan, Ulu, Kadir, Ünsal, Erbil, Yazıcı, Ayten, Gezgin Yıldırım, Deniz, Yüksel, Selçuk, Kasapçopur, Özgür, Özen, Seza, Aktay Ayaz, Nuray, and Sönmez, Hafize Emine

Published
2024
Full Text
View/download PDF

4. Urine soluble TLR4 levels may contribute to predict urinary tract infection in children: the UTILISE Study

Author

Aksu, Bagdagul, Afonso, Alberto Caldas, Akil, Ipek, Alpay, Harika, Atmis, Bahriye, Aydog, Ozlem, Bayazıt, Aysun Karabay, Bayram, Meral Torun, Bilge, Ilmay, Bulut, Ipek Kaplan, Buyukkaragoz, Bahar, Comak, Elif, Demir, Belde Kasap, Dincel, Nida, Donmez, Osman, Durmus, Mehmet Akif, Dursun, Hasan, Dusunsel, Ruhan, Duzova, Ali, Ertan, Pelin, Gedikbasi, Asuman, Goknar, Nilufer, Guven, Sercin, Hacihamdioglu, Duygu, Jankauskiene, Augustina, Kalyoncu, Mukaddes, Kavukcu, Salih, Kenan, Bahriye Uzun, Kucuk, Nuran, Kural, Bahar, Litwin, Mieczysław, Montini, Giovanni, Morello, William, Obrycki, Lukasz, Omer, Beyhan, Oner, Huseyin Adil, Ozdemir, Ebru Misirli, Ozkayin, Nese, Paripovic, Dusan, Pehlivanoglu, Cemile, Saygili, Seha, Schaefer, Franz, Schaefer, Susanne, Sonmez, Ferah, Tabel, Yilmaz, Tas, Nesrin, Tasdemir, Mehmet, Teixeira, Ana, Tekcan, Demet, Topaloglu, Rezan, Tulpar, Sebahat, Turkkan, Ozde Nisa, Uysal, Berfin, Uysalol, Metin, Vitkevic, Renata, Yavuz, Sevgi, Yel, Sibel, Yildirim, Tarik, Yildirim, Zeynep Yuruk, Yildiz, Nurdan, Yuksel, Selcuk, Yurtseven, Eray, and Yilmaz, Alev

Published
2024
Full Text
View/download PDF

5. Correction to: Adolescence‑onset atypical hemolytic uremic syndrome: is it different from infant‑onset?

Author

Celegen, Kubra, Gulhan, Bora, Fidan, Kibriya, Yuksel, Selcuk, Yilmaz, Neslihan, Yılmaz, Aysun Caltik, Demircioğlu Kılıç, Beltinge, Gokce, Ibrahim, Kavaz Tufan, Aslı, Kalyoncu, Mukaddes, Nalcacıoglu, Hulya, Ozlu, Sare Gulfem, Kurt Sukur, Eda Didem, Canpolat, Nur, K. Bayazit, Aysun, Çomak, Elif, Tabel, Yılmaz, Tulpar, Sebahat, Celakil, Mehtap, Bek, Kenan, Zeybek, Cengiz, Duzova, Ali, Özçakar, Zeynep Birsin, Topaloglu, Rezan, Soylemezoglu, Oguz, and Ozaltin, Fatih

Published
2024
Full Text
View/download PDF

6. How common is remission in rheumatoid factor-positive juvenile idiopathic arthritis patients? The multicenter Pediatric Rheumatology Academy (PeRA) research group experience

Author

Ozdel, Semanur, Sönmez, Hafize Emine, Çağlayan, Şengül, Akgün, Özlem, Aydın, Tuncay, Baba, Özge, Bağrul, İlknur, Yener, Gülçin Otar, Öztürk, Kübra, Demir, Ferhat, Yıldırım, Deniz Gezgin, Karadağ, Şerife Gül, Bağlan, Esra, Çakan, Mustafa, Kalyoncu, Mukaddes, Makay, Balahan Bora, Ünsal, Şevket Erbil, Bakkaloğlu, Sevcan, Bülbül, Mehmet, Sözeri, Betül, and Ayaz, Nuray Aktay

Published
2023
Full Text
View/download PDF

7. Steroid-Resistant Nephrotic Syndrome due to NPHS2 Variants Is Not Associated With Posttransplant Recurrence

Author

Boutaba, Mounia, Csaiscich, Dagmar, Baiko, Sergay, Azocar, Marta, Quiroz, Lily, Serna Higuita, Lina Maria, Dušek, Jiří, Ranchin, Bruno, Zaloszyc, Adriane, Davitaia, Tinatin, Gellermann, Jutta, Oh, Jun, Melk, Anette, Schaefer, Franz, Staude, Hagen, Printza, Nikoleta, Tory, Kalman, Gheissari, Alaleh, Remuzzi, Giuseppe, Pasini, Andrea, Ghiggeri, Gian Marco, Ardissino, Gianluigi, Benetti, Elisa, Emma, Francesco, Camilla, Roberta, Nigmatullina, Nazym, Aoun, Bilal, Mourani, Chebl, Abou-Jaoudé, Pauline, Jankauskiene, Augustina, Wasilewska, Anna, Klekot, Lidia Hyla, Zurowska, Aleksandra, Drozdz, Dorota, Tkaczyk, Marcin, Sikora, Przemysław, Ostalska, Danuta, Brodkiewicz, Andrzej, Litwin, Mieczyslaw, Panczyk-Tomaszewska, Małgorzata, Medyńska, Anna, Szczepanska, Maria, Afonso, Alberto Caldas, Jardim, Helena, Lungu, Adrian, Tsygin, Alexej, Prikhodina, Larisa, Paripovic, Dusan, Bogdanovic, Radovan, Krmar, Rafael T., Saeed, Bassam, Anarat, Ali, Balat, Ayse, Baskin, Z. Esra, Cakar, Nilgun, Erdogan, Ozlem, Özcakar, Birsin, Ozaltin, Fatih, Sakallioglu, Onur, Soylemezoglu, Oguz, Akman, Sema, Gok, Faysal, Caliskan, Salim, Candan, Cengiz, Yilmaz, Alev, Sozeri, Betul, Akil, Ipek, Ertan, Pelin, Özkaya, Ozan, Kalyoncu, Mukaddes, Bitzan, Martin, Formina, Svitlana, Sobko, Roman, Kachmar, Jessica, Boyer, Olivia, Lipska-Ziętkiewicz, Beata, Morinière, Vincent, Gribouval, Olivier, Heidet, Laurence, Balasz-Chmielewska, Irena, Cloarec, Sylvie, Csaicsich, Dagmar, Decramer, Stéphane, Guigonis, Vincent, Hogan, Julien, Bayazit, Aysun Karabay, Tsimaratos, Michel, Trautmann, Agnes, Antignac, Corinne, and Dorval, Guillaume

Published
2024
Full Text
View/download PDF

8. Lupus low disease activity state as a treatment target for pediatric patients with lupus nephritis

Author

Kisaoglu, Hakan, Baba, Ozge, and Kalyoncu, Mukaddes

Subjects
Children -- Diseases, Lupus -- Diagnosis -- Care and treatment -- Complications and side effects, Health
Abstract

Background Lupus low disease activity state (LLDAS) is a treatment target for patients with SLE and is associated with decreased risk for severe flare and new damage. We investigated the utility of the achievement of LLDAS in children with lupus nephritis and whether attainment of LLDAS is associated with more favorable outcomes. Methods Data of children, diagnosed with biopsy-proven lupus nephritis between January 2012 and December 2020, were retrospectively analyzed. Results For patients who did not achieve LLDAS after initial treatment (first 6 months), presence of autoimmune hemolytic anemia (62% vs. 18%, p = 0.047), anti-Sm (85% vs. 18%, p = 0.003) and anti-dsDNA (77% vs. 27%, p = 0.038) antibodies, proliferative lupus nephritis (77% vs. 27%, p = 0.038), and hypertension (69% vs. 9%, p = 0.005) at onset were more frequently encountered. Also, a lower rate of complete kidney response (43% vs. 100%, p = 0.005) and a higher rate of hypertension (86% vs. 13%, p = 0.002) were observed in patients who did not achieve LLDAS-50, defined as being in LLDAS at least 50% of the observation time. Attainment of both LLDAS after initial treatment and LLDAS-50 were associated with lower rates of kidney flare (p = 0.001 and p = 0.002, respectively) and damage accrual (p = 0.007 and p = 0.02, respectively) through the observation period. Conclusions LLDAS is an attainable treatment target for children with lupus nephritis and associated with lower rates of kidney flare and damage. Presence of hematologic involvement, hypertension, and proliferative lupus nephritis at onset adversely influenced the early achievement of LLDAS. Graphical abstract, Author(s): Hakan Kisaoglu [sup.1] , Ozge Baba [sup.1] , Mukaddes Kalyoncu [sup.1] [sup.2] Author Affiliations: (1) grid.31564.35, 0000 0001 2186 0630, Division of Pediatric Rheumatology, Karadeniz Technical University Faculty of [...]

Published
2023
Full Text
View/download PDF

9. Urinary HSP70 improves diagnostic accuracy for urinary tract infection in children: UTILISE study

Author

Yilmaz, Alev, Afonso, Alberto Caldas, Akil, Ipek, Aksu, Bagdagul, Alpay, Harika, Atmis, Bahriye, Aydog, Ozlem, Bayazıt, Aysun Karabay, Bayram, Meral Torun, Bilge, Ilmay, Bulut, Ipek Kaplan, Buyukkaragoz, Bahar, Comak, Elif, Demir, Belde Kasap, Dincel, Nida, Donmez, Osman, Durmus, Mehmet Akif, Dursun, Hasan, Dusunsel, Ruhan, Duzova, Ali, Ertan, Pelin, Gedikbasi, Asuman, Goknar, Nilufer, Guven, Sercin, Hacihamdioglu, Duygu, Jankauskiene, Augustina, Kalyoncu, Mukaddes, Kavukcu, Salih, Kenan, Bahriye Uzun, Kucuk, Nuran, Kural, Bahar, Litwin, Mieczysław, Montini, Giovanni, Morello, William, Nayir, Ahmet, Obrycki, Lukasz, Omer, Beyhan, Ozdemir, Ebru Misirli, Ozkayin, Nese, Paripovic, Dusan, Pehlivanoglu, Cemile, Saygili, Seha, Schaefer, Susanne, Sonmez, Ferah, Tabel, Yilmaz, Tas, Nesrin, Tasdemir, Mehmet, Teixeira, Ana, Tekcan, Demet, Tulpar, Sebahat, Turkkan, Ozde Nisa, Uysal, Berfin, Uysalol, Metin, Vaiciuniene, Daiva, Yavuz, Sevgi, Yel, Sibel, Yildirim, Tarik, Yildirim, Zeynep Yuruk, Yildiz, Nurdan, Yuksel, Selcuk, Yurtseven, Eray, Schaefer, Franz, and Topaloglu, Rezan

Published
2023
Full Text
View/download PDF

10. Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: A multicenter study

Author

Kısaarslan, Ayşenur Paç, Çiçek, Sümeyra Özdemir, Batu, Ezgi D., Şahin, Sezgin, Gürgöze, Metin K., Çetinkaya, Sibel Balcı, Ekinci, Miray Kışla, Atmış, Bahriye, Barut, Kenan, Adrovic, Amra, Ağar, Buket Esen, Şahin, Nihal, Demir, Ferhat, Bağlan, Esra, Kara, Mehtap Akbalık, Selçuk, Şenay Zırhlı, Özdel, Semanur, Çomak, Elif, Akkoyunlu, Betül, Yener, Gülçin Otar, Yıldırım, Deniz Gezgin, Öztürk, Kübra, Yıldız, Mehmet, Haşlak, Fatih, Şener, Seher, Kısaoğlu, Hakan, Baba, Özge, Kızıldağ, Zehra, İşgüder, Rana, Çağlayan, Şengül, Bilgin, Raziye B. Güven, Aytaç, Gülçin, Yücel, Burcu Bozkaya, Tanatar, Ayşe, Sönmez, Hafize E., Çakan, Mustafa, Kara, Aslıhan, Elmas, Ahmet T., Kılıç, Beltinge Demircioğlu, Ayaz, Nuray Aktay, Kasap, Belde, Acar, Banu Çelikel, Ozkaya, Ozan, Yüksel, Selçuk, Bakkaloğlu, Sevcan, Aydoğ, Özlem, Aksu, Güzide, Akman, Sema, Dönmez, Osman, Bülbül, Mehmet, Büyükçelik, Mithat, Tabel, Yılmaz, Sözeri, Betül, Kalyoncu, Mukaddes, Bilginer, Yelda, Poyrazoğlu, Muammer H., Ünsal, Erbil, Kasapçopur, Özgür, Özen, Seza, and Düşünsel, Ruhan

Published
2023
Full Text
View/download PDF

13. The clinical course of SARS-CoV-2 infection among children with rheumatic disease under biologic therapy: a retrospective and multicenter study

Author

Sozeri, Betul, Ulu, Kadir, Kaya-Akça, Ummusen, Haslak, Fatih, Pac-Kisaarslan, Aysenur, Otar-Yener, Gulcin, Baba, Ozge, Altug-Gucenmez, Ozge, Sahin, Nihal, Bağlan, Esra, Sönmez, Hafize Emine, Cakmak, Figen, Ozturk, Kubra, Gezgin-Yıldırım, Deniz, Şener, Seher, Barut, Kenan, Batu, Ezgi Deniz, Yıldız, Mehmet, Basaran, Ozge, Adrovic, Amra, Sahin, Sezgin, Ozdel, Semanur, Bilginer, Yelda, Poyrazoglu, Muammer Hakan, Demir, Ferhat, Yuksel, Selcuk, Kalyoncu, Mukaddes, Kasapcopur, Ozgur, Ozen, Seza, and Aktay-Ayaz, Nuray

Published
2022
Full Text
View/download PDF

14. Impact of serological activity on flare following clinically inactive disease and remission in childhood-onset systemic lupus erythematosus.

Author

Kisaoglu, Hakan, Sener, Seher, Aslan, Esma, Baba, Ozge, Sahin, Sezgin, Bilginer, Yelda, Kasapcopur, Ozgur, Ozen, Seza, and Kalyoncu, Mukaddes

Subjects
DRUG therapy, SYSTEMIC lupus erythematosus, DISEASE remission, RETROSPECTIVE studies, DESCRIPTIVE statistics, PREDNISOLONE, AGE factors in disease, LONGITUDINAL method, ODDS ratio, DISEASE relapse, CONFIDENCE intervals, GLUCOCORTICOIDS
Abstract

Objectives The objectives of this study were to assess the association between serological activity (SA) and clinical inactivity in SLE and to investigate whether SA predicts flare after the attainment of clinically inactive disease (CID) and remission. Methods The longitudinal data of children from three paediatric rheumatology referral centres were retrospectively reviewed. CID was interpreted as the beginning of a transitional phase of clinical inactivity on a moderate glucocorticoid dose during which tapering was expected and defined as the absence of disease activity in clinical domains of SLEDAI, without haemolytic anaemia or gastrointestinal activity, in patients using <15 mg/day prednisolone treatment. Modified DORIS remission on treatment criteria were used to determine remission. Results Of the 124 patients included, 89.5% displayed SA at onset. Through follow-up, the rate of SA decreased to 43.3% at first CID and 12.1% at remission. Among the patients with CID, 24 (20.7%) experienced a moderate-to-severe flare before the attainment of remission. While previous proliferative LN [odds ratio (OR): 10.2, P : 0.01) and autoimmune haemolytic anaemia (OR: 6.4, P : 0.02) were significantly associated with increased odds of flare after CID, SA at CID was not associated with flare. In contrast, 21 (19.6%) patients experienced flare in a median of 18 months after remission. Hypocomplementemia (OR: 9.8, P : 0.02) and a daily HCQ dose of <5 mg/kg (OR: 5.8, P : 0.02) during remission significantly increased the odds of flare. Conclusion SA during remission increases the odds of flare, but SA at CID does not. Suboptimal dosing of HCQ should be avoided, especially in children with SA in remission, to lower the risk of flares. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

15. Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis on anti-interleukin-1 or -6 therapy

Author

Ulu, Kadir, primary, Aliyev, Emil, additional, Kılıç Könte, Elif, additional, Tanatar, Ayşe, additional, Türkmen, Şeyma, additional, Doğantan, Şeyda, additional, Kızıldağ, Zehra, additional, Kasap Demir, Belde, additional, Gezgin Yıldırım, Deniz, additional, Otar Yener, Gülçin, additional, Öztürk, Kübra, additional, Baba, Özge, additional, Açarı, Ceyhun, additional, Kılbaş, Gülşah, additional, Taşkın, Sema Nur, additional, Haşlak, Fatih, additional, Çağlayan, Şengül, additional, Bağlan, Esra, additional, Dundar, Hatice Adıgüzel, additional, Başaran, Özge, additional, Barut, Kenan, additional, Karadağ, Şerife Gül, additional, Coşkuner, Taner, additional, Sönmez, Hafize Emine, additional, Yüksel, Selçuk, additional, Kalyoncu, Mukaddes, additional, Bakkaloğlu, Sevcan A, additional, Ünsal, Erbil, additional, Paç Kısaarslan, Ayşenur, additional, Bilginer, Yelda, additional, Aktay Ayaz, Nuray, additional, Kasapçopur, Özgür, additional, Özen, Seza, additional, and Sözeri, Betül, additional

Published
2024
Full Text
View/download PDF

16. The relationship between urine heat shock protein 70 and congenital anomalies of the kidney and urinary tract: UTILISE study

Author

Aksu, Bagdagul, primary, Afonso, Alberto Caldas, additional, Akil, Ipek, additional, Alpay, Harika, additional, Atmis, Bahriye, additional, Aydog, Ozlem, additional, Bakkaloglu, Sevcan, additional, Bayazıt, Aysun Karabay, additional, Bayram, Meral Torun, additional, Bilge, Ilmay, additional, Bulut, Ipek Kaplan, additional, Cetinkaya, Ayse Pinar Goksu, additional, Comak, Elif, additional, Demir, Belde Kasap, additional, Dincel, Nida, additional, Donmez, Osman, additional, Durmus, Mehmet Akif, additional, Dursun, Hasan, additional, Dusunsel, Ruhan, additional, Duzova, Ali, additional, Ertan, Pelin, additional, Gedikbasi, Asuman, additional, Goknar, Nilufer, additional, Guven, Sercin, additional, Hacihamdioglu, Duygu, additional, Jankauskiene, Augustina, additional, Kalyoncu, Mukaddes, additional, Kavukcu, Salih, additional, Kenan, Bahriye Uzun, additional, Kucuk, Nuran, additional, Kural, Bahar, additional, Litwin, Mieczysław, additional, Montini, Giovanni, additional, Morello, William, additional, Obrycki, Lukasz, additional, Omer, Beyhan, additional, Misirli Ozdemir, Ebru, additional, Ozkayin, Nese, additional, Paripovic, Dusan, additional, Pehlivanoglu, Cemile, additional, Saygili, Seha, additional, Schaefer, Franz, additional, Schaefer, Susanne, additional, Sonmez, Ferah, additional, Tabel, Yilmaz, additional, Tas, Nesrin, additional, Tasdemir, Mehmet, additional, Teixeira, Ana, additional, Tekcan, Demet, additional, Topaloglu, Rezan, additional, Tulpar, Sebahat, additional, Turkkan, Ozde Nisa, additional, Uysal, Berfin, additional, Uysalol, Metin, additional, Vitkevic, Renata, additional, Yavuz, Sevgi, additional, Yel, Sibel, additional, Yildirim, Tarik, additional, Yildirim, Zeynep Yuruk, additional, Yildiz, Nurdan, additional, Yuksel, Selcuk, additional, Yurtseven, Eray, additional, and Yilmaz, Alev, additional

Published
2024
Full Text
View/download PDF

20. Associations of Raynaud's Phenomenon in Juvenile Onset Systemic Lupus Erythematosus.

Author

Baba, Ozge, Kisaoglu, Hakan, and Kalyoncu, Mukaddes

Subjects
RAYNAUD'S disease, JUVENILE diseases, SYSTEMIC lupus erythematosus
Abstract

Introduction: Raynaud’s phenomenon (RP) is associated with mild disease in adults with systemic lupus erythematosus (SLE). Although RP is more frequently reported in juvenile onset SLE (jSLE) clinical associations were not studied. We aimed to investigate whether the presence of RP is associated with clinical and serological features at onset and outcomes in children with SLE. Methods: Medical charts of children diagnosed with jSLE were reviewed. The presence of RP was evaluated by the presence of patients reporting symptoms, and patients were compared according to the presence of RP. Results: Among the 52 included patients, 13 (25.0%) displayed RP. The clinical and laboratory features did not significantly differ according to the presence of RP. However, positive anti-dsDNA (76.9% vs. 35.8%), anti-RNP (53.8% vs. 17.9%), and anti-centromere (23.0% vs. 2.5%) antibodies were more frequently observed in patients with RP than in those without. RP was not found to be associated with initial disease severity, flare rate, remission, or damage accrual. Conclusion: RP was associated with certain serological features. However, RP was not strongly associated with clinical features. Moreover, neither disease severity nor disease outcomes differed according to the presence of RP in children with SLE. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

23. The safety of canakinumab in systemic juvenile idiopathic arthritis and autoinflammatory diseases in pediatric patients: a multicenter study

Author

Coşkuner, Taner, primary, Çağlayan, Şengül, additional, Akgün, Özlem, additional, Torun, Rüya, additional, Yayla, Emine Nur Sunar, additional, Bagrul, İ̇lknur, additional, Kılbaş, Gülşah, additional, Yener, Gülçin Otar, additional, Köse, Hülya, additional, Öztürk, Kübra, additional, Baba, Özge, additional, Çakan, Mustafa, additional, Demir, Ferhat, additional, Sönmez, Hafize Emine, additional, Kalyoncu, Mukaddes, additional, Kılıç, Sara Sebnem, additional, Yüksel, Selçuk, additional, Bağlan, Esra, additional, Bakkaloğlu, Sevcan A, additional, Ünsal, Erbil, additional, Aktay Ayaz, Nuray, additional, and Sözeri, Betül, additional

Published
2023
Full Text
View/download PDF

29. Urine soluble TLR4 levels may contribute to predict urinary tract infection in children: the UTILISE Study

Author

Aksu, Bagdagul, primary, Afonso, Alberto Caldas, additional, Akil, Ipek, additional, Alpay, Harika, additional, Atmis, Bahriye, additional, Aydog, Ozlem, additional, Bayazıt, Aysun Karabay, additional, Bayram, Meral Torun, additional, Bilge, Ilmay, additional, Bulut, Ipek Kaplan, additional, Buyukkaragoz, Bahar, additional, Comak, Elif, additional, Demir, Belde Kasap, additional, Dincel, Nida, additional, Donmez, Osman, additional, Durmus, Mehmet Akif, additional, Dursun, Hasan, additional, Dusunsel, Ruhan, additional, Duzova, Ali, additional, Ertan, Pelin, additional, Gedikbasi, Asuman, additional, Goknar, Nilufer, additional, Guven, Sercin, additional, Hacihamdioglu, Duygu, additional, Jankauskiene, Augustina, additional, Kalyoncu, Mukaddes, additional, Kavukcu, Salih, additional, Kenan, Bahriye Uzun, additional, Kucuk, Nuran, additional, Kural, Bahar, additional, Litwin, Mieczysław, additional, Montini, Giovanni, additional, Morello, William, additional, Obrycki, Lukasz, additional, Omer, Beyhan, additional, Oner, Huseyin Adil, additional, Ozdemir, Ebru Misirli, additional, Ozkayin, Nese, additional, Paripovic, Dusan, additional, Pehlivanoglu, Cemile, additional, Saygili, Seha, additional, Schaefer, Franz, additional, Schaefer, Susanne, additional, Sonmez, Ferah, additional, Tabel, Yilmaz, additional, Tas, Nesrin, additional, Tasdemir, Mehmet, additional, Teixeira, Ana, additional, Tekcan, Demet, additional, Topaloglu, Rezan, additional, Tulpar, Sebahat, additional, Turkkan, Ozde Nisa, additional, Uysal, Berfin, additional, Uysalol, Metin, additional, Vitkevic, Renata, additional, Yavuz, Sevgi, additional, Yel, Sibel, additional, Yildirim, Tarik, additional, Yildirim, Zeynep Yuruk, additional, Yildiz, Nurdan, additional, Yuksel, Selcuk, additional, Yurtseven, Eray, additional, and Yilmaz, Alev, additional

Published
2023
Full Text
View/download PDF

31. Evaluation of childhood malignancies presenting with musculoskeletal manifestations from two different divisions: a multicenter study.

Author

Çağlayan, Şengül, Koç, Begüm Şirin, Baba, Özge, Bağlan, Esra, Kurucu, Burçak, Yıldırım, Deniz Gezgin, Ayhan, Aylin Canbolat, Çakan, Mustafa, Yener, Gülçin Otar, Öztürk, Kübra, Çakmak, Figen, Sönmez, Hafize Emine, Ayaz, Nuray Aktay, Kısaarslan, Ayşenur Paç, Bakkaloğlu, Sevcan, Kalyoncu, Mukaddes, Kılıç, Suar Çakı, and Sözeri, Betül

Abstract

Background: The aim of the study was to evaluate the approaches of pediatric rheumatologists and pediatric hematologists to patients with similar musculoskeletal (MSK) complaints and to highlight the differences that general pediatricians should consider when referring patients to these specialties. Methods: This is a cross-sectional study involving the patients who applied to pediatric rheumatology centers with MSK complaints and were diagnosed with malignancy, as well as patients who were followed up in pediatric hematology centers with a malignancy diagnosis, and had MSK complaints at the time of admission. Results: A total of 142 patients were enrolled in the study. Of these patients, 83 (58.4%) applied to pediatric rheumatology centers, and 59 (41.6%) applied to pediatric hematology centers. Acute lymphoblastic leukemia (ALL) was the most common diagnosis among the patients who applied to both centers, with 80 cases (56.3%). The median age of diagnosis was 87 (interquartile range, IQR: 48-140) months. The most common preliminary diagnosis in pediatric rheumatology centers was juvenile idiopathic arthritis (JIA), with 37 cases (44.5%). MSK involvement was mainly seen as arthralgia, and bone pain. While arthralgia (92.7%) was the most common complaint in rheumatology centers, bone pain (88.1%) was more common in hematology centers. The most frequently involved joints were the knee (62.9%), ankle (25.9%), hip (25%), and wrist (14%). The most common laboratory abnormalities were high lactate dehydrogenase (LDH), high C-reactive protein (CRP), anemia, and high erythrocyte sedimentation rate (ESR). Thrombocytopenia, neutropenia, and high LDH were statistically significantly more frequent in patients admitted to hematology centers than in patients admitted to rheumatology centers (p<0.001, p=0.014, p=0.028, respectively). Patients who applied to rheumatology clinics were found to have statistically significantly higher CRP levels (p=0.032). Conclusions. Malignancies may present with only MSK system complaints in childhood. Therefore, malignancies should be included in the differential diagnosis of patients presenting with MSK complaints. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

32. Anterior Chest Wall Involvement in a Child with Familial Mediterranean Fever: A Rare Manifestation and Diagnostic Challenge.

Author

KISAOĞLU, Hakan, BABA, Özge, and KALYONCU, Mukaddes

Abstract

Copyright of Turkiye Klinikleri Journal of Pediatrics / Türkiye Klinikleri Pediatri Dergisi is the property of Turkiye Klinikleri and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Published
2024
Full Text
View/download PDF

33. Clinical Characteristics and Short-term Outcomes of Paediatric Patients with Chronic Recurrent Multifocal Osteomyelitis.

Author

Baba, Özge, Kısaoğlu, Hakan, and Kalyoncu, Mukaddes

Subjects
VASCULITIS, DIAGNOSTIC imaging, PSORIASIS, OSTEOMYELITIS, IMMUNOGLOBULINS, METHOTREXATE, EVALUATION of medical care, RETROSPECTIVE studies, AUTOINFLAMMATORY diseases, MAGNETIC resonance imaging, DESCRIPTIVE statistics, CHRONIC diseases, CLINICAL pathology, ETANERCEPT, DISEASE relapse, INFLIXIMAB, CHILDREN
Abstract

Objective: Chronic recurrent multifocal osteomyelitis (CRMO) is the most common autoinflammatory disease of the bone characterized by pain and inflammatory lesions without an infectious agent. The aim of this study is to evaluate the clinical, laboratory, and imaging features and treatments of paediatric patients with CRMO followed in our pediatric rheumatology clinic. Material and Methods: Medical records of ten patients diagnosed with CRMO according to Bristol diagnostic criteria between January 2018 and June 2021 were retrospectively reviewed. Results: The mean age at diagnosis was 9.3 years, and eight of the patients were male. One patient had concomitant psoriasis, two patients had familial Mediterranean fever and one patient had a history of immunoglobulin A vasculitis. Half of the patients had a moderate acute phase reactant elevation. The most frequently involved bones were the lower extremity bones. While localized magnetic resonance imaging (MRI) was the most commonly used imaging modality in the diagnosis of CRMO, silent bone lesions (15%) were detected only by the whole-body MRI. Non-steroidal anti-inflammatory drug (NSAID) was given to all patients. As second-line therapy, methotrexate and pamidronate were employed on seven and five patients respectively. Three of the patients received anti-TNF treatment (etanercept and infliximab) as the third-line therapy. Imaging with whole-body MRI is important due to clinically silent bone lesions, especially in the course of CRMO. Conclusion: Concomitant familial Mediterranean fever was not rare in cases with CRMO and treatment of CRMO might be challenging due to the need for anti-TNF treatment in a considerable number of patients. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

36. COVID-19 in pediatric nephrology centers in Turkey

Author

Taşdemir, Mehmet (ORCID 0000-0002-5579-6339 & YÖK ID 175867); Bilge, İlmay (ORCID 0000-0002-4852-989X & YÖK ID 198907), Leventoglu, Emre; Ozdemir Atikel, Yesim; Nalcacioglu, Hulya; Dursun, Ismail; Dursun, Hasan; Yuruk Yildirim, Zeynep; Yildiz, Nurdan; Kaya Aksoy, Gulsah; Celakil, Mehtap; Demircioglu Kilic, Beltinge; Zirhli Selcuk, Sena; Canpolat, Nur; Kargin Cakici, Evrim; Ozlu, Sare Gulfem; Tulpar, Sebahat; Yuksel, Selcuk; Atmis, Bahriye; Surmeli Doven, Serra; Taner, Sevgin; Ertan, Pelin; Kavaz, Asli; Torun Bayram, Meral; Kalyoncu, Mukaddes; Gulleroglu, Kaan; Kabasakal, Caner; Kasap Demir, Belde; Cicek, Rumeysa Yasemin; Donmez, Osman; Kara, Aslihan; Yavascan, Onder; Ozcelik, Gul; Gezgin Yildirim, Deniz; Guler, Muhammet Akif; Sonmez, Ferah; Poyrazoglu, Hakan; Akman, Sema; Topaloglu, Rezan; Alpay, Harika; Bakkaloglu, Sevcan A., School of Medicine, Taşdemir, Mehmet (ORCID 0000-0002-5579-6339 & YÖK ID 175867); Bilge, İlmay (ORCID 0000-0002-4852-989X & YÖK ID 198907), Leventoglu, Emre; Ozdemir Atikel, Yesim; Nalcacioglu, Hulya; Dursun, Ismail; Dursun, Hasan; Yuruk Yildirim, Zeynep; Yildiz, Nurdan; Kaya Aksoy, Gulsah; Celakil, Mehtap; Demircioglu Kilic, Beltinge; Zirhli Selcuk, Sena; Canpolat, Nur; Kargin Cakici, Evrim; Ozlu, Sare Gulfem; Tulpar, Sebahat; Yuksel, Selcuk; Atmis, Bahriye; Surmeli Doven, Serra; Taner, Sevgin; Ertan, Pelin; Kavaz, Asli; Torun Bayram, Meral; Kalyoncu, Mukaddes; Gulleroglu, Kaan; Kabasakal, Caner; Kasap Demir, Belde; Cicek, Rumeysa Yasemin; Donmez, Osman; Kara, Aslihan; Yavascan, Onder; Ozcelik, Gul; Gezgin Yildirim, Deniz; Guler, Muhammet Akif; Sonmez, Ferah; Poyrazoglu, Hakan; Akman, Sema; Topaloglu, Rezan; Alpay, Harika; Bakkaloglu, Sevcan A., and School of Medicine

Abstract

Background/aim: There is limited data on COVID-19 disease in children with kidney disease. We aimed to investigate the characteristics and prognosis of COVID-19 in pediatric nephrology patients in Turkey. Materials and methods: This was a national, multicenter, retrospective cohort study based on an online survey evaluating the data between 11th March 2020 and 11th March 2021 as an initial step of a detailed pediatric nephrology COVID-19 registry. Results: Two hundred and three patients (89 girls and 114 boys) were diagnosed with COVID-19. One-third of these patients (36.9%) were between 10-15 years old. Half of the patients were on kidney replacement therapy: kidney transplant (KTx) recipients (n = 56, 27.5%), patients receiving chronic hemodialysis (n = 33, 16.3%) and those on peritoneal dialysis (PD) (n = 18, 8.9%). Fifty-four (26.6%) children were asymptomatic. Eighty-two (40.3%) patients were hospitalized and 23 (28%) needed intensive care unit admission. Fifty-five percent of the patients were not treated, while the remaining was given favipiravir (20.7%), steroid (16.3%), and hydroxychloroquine (11.3%). Acute kidney injury developed in 19.5% of hospitalized patients. Five (2.4%) had MIS-C. Eighty-three percent of the patients were discharged without any apparent sequelae, while 7 (3.4%) died. One hundred and eight health care staff were infected during the study period. Conclusion: COVID-19 was most commonly seen in patients who underwent KTx and received HD. The combined immunosuppressive therapy and frequent exposure to the hospital setting may increase these patients' susceptibility. Staff infections before vaccination era were alarming, various precautions should be taken for infection control, particularly optimal vaccination coverage., NA

Published
2023

37. Ultrasound evaluation of cartilage and enthesis thicknesses in healthy children: A pilot study.

Author

Sözeri, Betül, Demir, Ferhat, Dündar, Hatice Adıgüzel, Balcı, Sibel, Şahin, Sezgin, Açarı, Ceyhun, Kışla Ekinci, Rabia Miray, Kalyoncu, Mukaddes, Kasapçopur, Özgur, and Ünsal, Erbil

Subjects
LEG physiology, KNEE joint, CARTILAGE, PILOT projects, RESEARCH, ACHILLES tendon, CROSS-sectional method, MUSCULOSKELETAL system, SEX distribution, DOPPLER ultrasonography, DESCRIPTIVE statistics, PATELLAR tendon, CHILDREN
Abstract

Copyright of Ümraniye Pediatri Dergisi is the property of KARE Publishing and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Published
2023
Full Text
View/download PDF

41. CLINICAL COURSE OF ADOLESCENT ONSET ATYPICAL HEMOLYTIC UREMIC SYNDROME: A STUDY OF TURKISH AHUS REGISTRY

Author

KARABAY BAYAZIT, AYSUN, Ozlu, Sare Gulfem, Celegen, Kubra, Zeybek, Cengiz, Soylemezoglu, Oguz, Nalcacioglu, Hulya, ÖZALTIN, FATİH, KILIÇ, BELTİNGE DEMİRCİOĞLU, Canpolat, Nur, BEK, KENAN, Celakil, Mehtap, Tulpar, Sebahat, TABEL, YILMAZ, Yilmaz, Aysun Caltik, Sukur, Eda Didem Kurt, ÖZÇAKAR, ZEYNEP BİRSİN, DÜZOVA, ALİ, TOPALOĞLU, REZAN, GÖKCE, İBRAHİM, KOYUN, MUSTAFA, KAVAZ TUFAN, ASLI, Yilmaz, Neslihan, KALYONCU, MUKADDES, YÜKSEL, SELÇUK, FİDAN, HATİCE KİBRİYA, and GÜLHAN, BORA

Published
2022

42. The clinical course of SARS-CoV-2 infection among children with rheumatic disease under biologic therapy: a retrospective and multicenter study

Author

Sozeri, Betul, Ulu, Kadir, Kaya-Akça, Ummusen, Haslak, Fatih, Pac-Kisaarslan, Aysenur, Otar-Yener, Gulcin, Baba, Ozge, Altug-Gucenmez, Ozge, Sahin, Nihal, Bağlan, Esra, Sönmez, Hafize Emine, Cakmak, Figen, Ozturk, Kubra, Gezgin-Yıldırım, Deniz, Şener, Seher, Barut, Kenan, Batu, Ezgi Deniz, Yıldız, Mehmet, Basaran, Ozge, Adrovic, Amra, Sahin, Sezgin, Ozdel, Semanur, Bilginer, Yelda, Poyrazoglu, Muammer Hakan, Demir, Ferhat, Yuksel, Selcuk, Kalyoncu, Mukaddes, Kasapcopur, Ozgur, Ozen, Seza, and Aktay-Ayaz, Nuray

Subjects
Male, polymerase chain reaction, retrospective study, Observational Research, Pediatrics, Etanercept, computer assisted tomography, chemistry.chemical_compound, rituximab, adalimumab, Severe acute respiratory syndrome coronavirus 2, Immunology and Allergy, Child, connective tissue, azithromycin, tofacitinib, Biologic drugs, disease course, artificial ventilation, hospital patient, biological therapy, Antirheumatic Agents, Disease Progression, Female, biological product, pediatric patient, anakinra, hospitalization, medicine.drug, medicine.medical_specialty, abatacept, Adolescent, prevalence, Immunology, complication, canakinumab, Article, tocilizumab, coronavirus disease 2019, Tocilizumab, Rheumatology, Rheumatic Diseases, Internal medicine, medicine, Adalimumab, Humans, human, Retrospective Studies, Biological Products, Anakinra, business.industry, Abatacept, COVID-19, major clinical study, Infliximab, enzyme linked immunosorbent assay, Canakinumab, multicenter study, chemistry, antirheumatic agent, disease exacerbation, Rheumatic disease, business, disease activity
Abstract

The effects of biological disease-modifying antirheumatic drugs (bDMARDs) in the clinical course of COVID-19 on children with underlying rheumatologic diseases have not been fully demonstrated. To evaluate the course of COVID-19 infection in patients with rheumatic disease receiving bDMARD treatment. This was a retrospective, multicenter study conducted in pediatric patients infected by SARS-CoV-2 and under bDMARDs therapy. The study population consisted of 113 patients (72 female/41 male). The mean age of the patients was 12.87 ± 4.69 years. The primary diagnosis of the cohort was as follows: 63 juvenile idiopathic arthritis, 35 systemic autoinflammatory diseases, 10 vasculitides, and five cases of connective tissue diseases. The mean duration of the primary disease was 4.62 ± 3.65 years. A total of 19 patients had additional comorbid diseases. Thirty-five patients were treated with canakinumab, 25 with adalimumab, 18 with etanercept, 10 with infliximab, nine with tocilizumab, six with rituximab, four with anakinra, three with tofacitinib, and one with abatacept. The median exposure time of the biological drug was 13.5 months. Seventy-one patients had symptomatic COVID-19, while 42 were asymptomatic. Twenty-four patients required hospitalization. Five patients presented with MIS-C. The hospitalized patients were younger and had a shorter duration of rheumatic disease compared to ambulatory patients, although the difference was not statistically significant. Steroid usage, presence of fever, and dyspnea were more common among the hospitalized patients. A worsening in the course of both COVID-19 and current disease was not noticed under bDMARDs, however, to end with a strong conclusion multicentric international studies are required. © 2021, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Published
2021

46. Importance of Recognising Dysmorphic Features: Trichorhinophalangeal Syndrome.

Author

Baba, Özge, Kısaoğlu, Hakan, and Kalyoncu, Mukaddes

Subjects
MUSCULOSKELETAL pain, SYNDROMES, MITRAL valve prolapse, RARE diseases, EPIPHYSIS, FIBRODYSPLASIA ossificans progressiva
Abstract

Copyright of Journal of the Child / Çocuk Dergisi is the property of Journal of Child and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Published
2023
Full Text
View/download PDF

47. Urinary HSP70 improves diagnostic accuracy for urinary tract infection in children: UTILISE study

Author

Yilmaz, Alev, primary, Afonso, Alberto Caldas, additional, Akil, Ipek, additional, Aksu, Bagdagul, additional, Alpay, Harika, additional, Atmis, Bahriye, additional, Aydog, Ozlem, additional, Bayazıt, Aysun Karabay, additional, Bayram, Meral Torun, additional, Bilge, Ilmay, additional, Bulut, Ipek Kaplan, additional, Buyukkaragoz, Bahar, additional, Comak, Elif, additional, Demir, Belde Kasap, additional, Dincel, Nida, additional, Donmez, Osman, additional, Durmus, Mehmet Akif, additional, Dursun, Hasan, additional, Dusunsel, Ruhan, additional, Duzova, Ali, additional, Ertan, Pelin, additional, Gedikbasi, Asuman, additional, Goknar, Nilufer, additional, Guven, Sercin, additional, Hacihamdioglu, Duygu, additional, Jankauskiene, Augustina, additional, Kalyoncu, Mukaddes, additional, Kavukcu, Salih, additional, Kenan, Bahriye Uzun, additional, Kucuk, Nuran, additional, Kural, Bahar, additional, Litwin, Mieczysław, additional, Montini, Giovanni, additional, Morello, William, additional, Nayir, Ahmet, additional, Obrycki, Lukasz, additional, Omer, Beyhan, additional, Ozdemir, Ebru Misirli, additional, Ozkayin, Nese, additional, Paripovic, Dusan, additional, Pehlivanoglu, Cemile, additional, Saygili, Seha, additional, Schaefer, Susanne, additional, Sonmez, Ferah, additional, Tabel, Yilmaz, additional, Tas, Nesrin, additional, Tasdemir, Mehmet, additional, Teixeira, Ana, additional, Tekcan, Demet, additional, Tulpar, Sebahat, additional, Turkkan, Ozde Nisa, additional, Uysal, Berfin, additional, Uysalol, Metin, additional, Vaiciuniene, Daiva, additional, Yavuz, Sevgi, additional, Yel, Sibel, additional, Yildirim, Tarik, additional, Yildirim, Zeynep Yuruk, additional, Yildiz, Nurdan, additional, Yuksel, Selcuk, additional, Yurtseven, Eray, additional, Schaefer, Franz, additional, and Topaloglu, Rezan, additional

Published
2022
Full Text
View/download PDF

48. Long-Term Outcome of Steroid-Resistant Nephrotic Syndrome in Children

Author

Trautmann, Agnes, Schnaidt, Sven, Lipska-Ziętkiewicz, Beata S., Bodria, Monica, Ozaltin, Fatih, Emma, Francesco, Anarat, Ali, Melk, Anette, Azocar, Marta, Oh, Jun, Saeed, Bassam, Gheisari, Alaleh, Caliskan, Salim, Gellermann, Jutta, Higuita, Lina Maria Serna, Jankauskiene, Augustina, Drozdz, Dorota, Mir, Sevgi, Balat, Ayse, Szczepanska, Maria, Paripovic, Dusan, Zurowska, Alexandra, Bogdanovic, Radovan, Yilmaz, Alev, Ranchin, Bruno, Baskin, Esra, Erdogan, Ozlem, Remuzzi, Giuseppe, Firszt-Adamczyk, Agnieszka, Kuzma-Mroczkowska, Elzbieta, Litwin, Mieczyslaw, Murer, Luisa, Tkaczyk, Marcin, Jardim, Helena, Wasilewska, Anna, Printza, Nikoleta, Fidan, Kibriya, Simkova, Eva, Borzecka, Halina, Staude, Hagen, Hees, Katharina, Schaefer, Franz, Azocar, M, Quiroz, Lily, Higuita, LM Serna, Dušek, Jiří, Ranchin, B, Fischbach, Michel, Davitaia, Tinatin, Gellerman, J, Oh, J, Melk, A, Schaefer, F, Wigger, Marianne, Printza, N, Sallay, Peter, Gheissari, Alaleh, Noris, Marina, Pasini, Andrea, Ghiggeri, Gian Marco, Ardissino, Gianluigi, Benetti, Elisa, Emma, F, Aoun, Bilal, Abou-Jaoudé, Pauline, Jankauskiene, A, Wasilewska, A, Gacka, Ewa, Zurowska, A, Drozdz, D, Tkaczyk, M, Lodz, Małgorzata Stańczyk, Borzecka, H, Silska, Magdalena, Jarmolinski, Tomasz, Firszt-Adamczyk, A, Ksiazek, Joanna, Kuzma-Mroczkowska, E, Medynska, Anna, Szczepanska, M, Afonso, Alberto Caldas, Jardim, H, Belgrade, Amira Peco-Antic, Bogdanovic, R, Krmar, Rafael T, Simonetti, Giacomo D, Saeed, B, Anarat, A, Balat, A, Baskin, E, Cakar, Nilgun, Erdogan, O, Özcakar, Birsin, Ozaltin, F, Sakallioglu, Onur, Soylemezoglu, Oguz, Akman, Sema, Gok, Faysal, Caliskan, S, Candan, Cengiz, Yilmaz, A, Mir, S, Akil, Ipek, Ertan, Pelin, Özkaya, Ozan, Kalyoncu, Mukaddes, Simkova, E, Alhammadi, Entesar, and Sobko, Roman

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results